Praxsyn, Inc. facilitates and coordinates the dispensing of prescribed medications to patients by their doctors. These medications are topical gel-based, creams and ointments specifically formulated by the prescribing doctor for the patient. Patients apply these medications to the affected area with the goal of reducing the potential side effects as compared to using oral medications.
The PAWS Pet Company, Inc. (OTCQB:PAWS) (OTCPK:PAWS) is soon to become Praxsyn, Inc. This name change is part of the exciting transition strategy developed to take advantage of the changes underway in traditional medical services. We believe that great opportunities exist in pharmaceuticals and how they are delivered to the public.
SHOWS STRONG SALES IN JANUARY AND CONTINUED GROWTH IN FEBRUARY.
IRVINE, CA, Feb. 19, 2014 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that Mesa Pharmacy Inc. ("Mesa") has executed a marketing agreement with Trestles Pain Specialists LLC of San Juan Capistrano, California to expand sales within California and, eventually, in other states. Physician groups and industrial medical clinics in the central valley of California and other new locations throughout California will now be using the alternative transdermal medications Mesa compounds.
FDA Reclassification of Hydrocodone to Schedule II Could Boost Sales.
PALO ALTO, CA, Dec. 5, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that work on the name change to Praxsyn Corporation is nearing completion and that the Company expects to be able to file a request with FINRA early next week along with filing the necessary filings and disclosures with the SEC and the State of Illinois.
PALO ALTO, CA, Nov. 26, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that it intends to begin implementation of its In-Office Dispensing Program (IODP) during the first half of December 2013 through our Advanced Access Pharmacy Services, LLC (AAPS) subsidiary. Our director, Evon Midei, will head this program up. Evon has forty years of experience in the medical industry including managing pharmacies and hospitals, having served as the COO and acting CEO of St.
Palo Alto, CA – October 17, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that the three short-term convertible notes that were negotiated with Asher Enterprises, Inc. in 2012 have been paid in full. The final interest payment on the last of those notes was paid today.
The PAWS Pet Company, Inc. (OTCQB:PAWS), today announced that as part of its ongoing transition from the pet space to the pharmaceutical space the Company has begun the process of changing its name to Praxsyn Corporation and will also change its state of incorporation from from Illinois to Nevada.
Palo Alto, CA – Sept 10, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS) (OTCPK:PAWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc. dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to consumers.